<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.9.2 (http://www.squarespace.com/) on Thu, 11 Mar 2010 18:48:13 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>GroupNET research sites news</title><link>http://www.groupnetsites.com/home/</link><description></description><lastBuildDate>Thu, 30 Jul 2009 19:17:54 +0000</lastBuildDate><copyright>GroupNET Research Sites</copyright><language>en-US</language><generator>Squarespace Site Server v5.9.2 (http://www.squarespace.com/)</generator><item><title>We are currently interested in trials in the following indications:</title><dc:creator>Kayla Van Winkle</dc:creator><pubDate>Thu, 30 Jul 2009 19:15:53 +0000</pubDate><link>http://www.groupnetsites.com/home/2009/7/30/we-are-currently-interested-in-trials-in-the-following-indic.html</link><guid isPermaLink="false">227004:2482002:4789291</guid><description><![CDATA[<ul>
<li>Gastroenterology</li>
<li>Vaccines</li>
<li>Women's Health (Menopause, contraception..)</li>
<li>Sleep Studies</li>
<li>Endocrinology</li>
<li>Dermatology</li>
<li>and more...</li>
</ul>]]></description><wfw:commentRss>http://www.groupnetsites.com/home/rss-comments-entry-4789291.xml</wfw:commentRss></item></channel></rss>